Note to editors: Silicon Laboratories, Silicon Labs, the "S" symbol, and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.
Silicon Laboratories Inc. |
| |||||||||
Condensed Consolidated Statements of Operations |
| |||||||||
(In thousands, except per share data) |
| |||||||||
(Unaudited) |
| |||||||||
|
|
| |||||||||
|
| Three Months Ended |
| Year Ended |
| ||||||
|
| December 31, 2022 |
| January 1, 2022 |
| December 31, 2022 |
| January 1,
|
| ||
Revenues | $ 257,325 |
| $ 208,680 |
| $ 1,024,106 |
| $ 720,860 |
| ||
Cost of revenues | 100,028 |
| 80,849 |
| 381,549 |
| 295,468 |
| ||
Gross profit | 157,297 |
| 127,831 |
| 642,557 |
| 425,392 |
| ||
Operating expenses: |
|
|
|
|
|
|
|
| ||
Research and development | 86,649 |
| 71,705 |
| 332,326 |
| 273,208 |
| ||
Selling, general and administrative | 46,573 |
| 53,487 |
| 190,971 |
| 185,022 |
| ||
Operating expenses | 133,222 |
| 125,192 |
| 523,297 |
| 458,230 |
| ||
Operating income (loss) | 24,075 |
| 2,639 |
| 119,260 |
| (32,838) |
| ||
Other income (expense): |
|
|
|
|
|
|
|
| ||
Interest income and other, net | 4,299 |
| 2,595 |
| 13,915 |
| 5,696 |
| ||
Interest expense | (1,849) |
| (6,628) |
| (6,723) |
| (31,033) |
| ||
Income (loss) from continuing operations before income taxes | 26,525 |
| (1,394) |
| 126,452 |
| (58,175) |
| ||
Provision for income taxes | 1,579 |
| 884 |
| 38,450 |
| 13,427 |
| ||
| Equity-method earnings | 415 |
| 7,791 |
| 3,400 |
| 13,728 |
| ||
| Income (loss) from continuing operations | 25,361 |
| 5,513 |
| 91,402 |
| (57,874) |
| ||
| Income (loss) from discontinued operations, net of income taxes | -- |
| (8,611) |
| -- |
| 2,175,273 |
| ||
|
|
|
|
|
|
|
|
|
| ||
| Net income (loss) | $ 25,361 |
| $ (3,098) |
| $ 91,402 |
| $ 2,117,399 |
| ||
|
|
|
|
|
|
|
|
|
| ||
| Basic earnings (loss) per share: |
|
|
|
|
|
|
|
| ||
| Continuing operations | $ 0.78 |
| $ 0.14 |
| $ 2.61 |
| $ (1.35) |
| ||
| Net income | $ 0.78 |
| $ (0.08) |
| $ 2.61 |
| $ 49.44 |
| ||
|
|
|
|
|
|
|
|
|
| ||
| Diluted earnings (loss) per share: |
|
|
|
|
|
|
|
| ||
| Continuing operations | $ 0.76 |
| $ 0.13 |
| $ 2.54 |
| $ (1.35) |
| ||
| Net income | $ 0.76 |
| $ (0.08) |
| $ 2.54 |
| $ 47.78 |
| ||
|
|
|
|
|
|
|
|
|
| ||
| Weighted-average common shares outstanding: |
|
|
|
|
|
|
|
| ||
| Basic | 32,542 |
| 38,965 |
| 35,086 |
| 42,830 |
| ||
| Diluted | 33,265 |
| 41,031 |
| 36,042 |
| 44,315 |
| ||
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measurements
